Experts convene in Qatar to enhance lymphoma patient care
Tribune News Network
Doha
Roche Pharmaceuticals, through its local representative Ebn Sina Medical, a fully owned subsidiary of Aamal Company Q.P.S.C., convened a significant workshop dedicated to the advancements in lymphoma treatment, specifically targeting Diffuse Large B-Cell Lymphoma (DLBCL). This high-profile event, known as the Redefining Lymphoma Gulf Countries Annual Forum, served as a platform for knowledge exchange and collaborative discussion among leading hematology experts.
Thirteen distinguished professionals, representing Qatar, Kuwait, Oman, Egypt, and the United Kingdom, participated in this intensive forum.
The agenda centered on the most current updates in the clinical management pathways for DLBCL, a challenging hematological malignancy. Beyond the presentation of cutting-edge research and therapeutic strategies, the workshop facilitated an invaluable opportunity for these experts to share their firsthand experiences in treating DLBCL patients.
They delved into real-world treatment outcomes observed in their respective national healthcare systems, providing a rich tapestry of practical insights that complemented the theoretical advancements discussed.Professor Honar Cherif, head of NCCCR in Qatar, remarked, 'Organising such events is crucial for fostering collaboration and continuous medical education.
Pharmaceutical companies' role in facilitating these workshops is invaluable as it brings together experts who can exchange knowledge and advance patient care in hematology.'Dr. Wendy Osborne, Consultant Haematologist specialising in Lymphoma at Freeman Hospital, Newcastle, emphasised, 'Sharing experiences and getting exposed to different practices across the world are fundamental to improving patient outcomes.
I am highly appreciative of the quality of care in the region, and forums like these are essential for pushing the boundaries of lymphoma treatment and care.'
Omar Hamdy, Roche Qatar and Oman Lead, stated, 'Roche is proud to organize The Redefining Lymphoma Gulf Forum, an event that drives hematology innovation.
This forum enables Gulf healthcare professionals to share their experiences to improve patient care and create long-term lymphoma treatment strategies, aligning with Roche's core purpose.'
As part of Aamal Company's continued commitment to supporting Qatar's healthcare sector, Ebn Sina Medical remains focused on enhancing patient access to innovative treatments through strategic partnerships with leading global pharmaceutical companies.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Qatar Tribune
2 days ago
- Qatar Tribune
The View Hospital performs ME's1st magnetic surgery in pvt sector
Tribune News Network Doha The View Hospital, in affiliation with Cedars-Sinai, has announced the successful completion of the first magnetic duodenal-ileostomy procedure in the private sector in the Middle East. This groundbreaking revision surgery offers a solution for patients who have experienced weight regain following sleeve gastrectomy. The advanced, minimally invasive procedure was performed by Dr Jassim Fakhro, Consultant in Metabolic and Bariatric Surgery and Medical Director of Qatari Physicians at The View Hospital, in the presence of Prof Michel Gagner, a global pioneer in metabolic surgery and the inventor of the magnetic technique. Unlike conventional surgical approaches that require cutting or stapling, magnetic duodenal-ileostomy involves placing two rare-earth magnets into the small intestine — one in the duodenum and the other in the ileum. Over the course of a few days, the magnets gradually compress the tissue between them to form a secure, suture-free connection. This rerouting of the digestive tract enhances hormonal responses that regulate appetite and metabolism, supporting long-term weight loss while reducing the risks and recovery time associated with traditional surgery. 'Bariatric surgery has long been the most reliable and effective way we have for treating the severe obesity. Now, with the successful use of magnetic anastomosis we can lower the risk of complications like bleeding and leakage. Our most effective operations for the treatment of obesity are now safer than ever thanks to magnetic compression anastomosis,' said Dr Jassim Fakhro. 'We are proud to be the first private hospital in Qatar to experience this transformative platform. As a health system dedicated to remaining at the forefront of medical technology and innovation, we are excited about adopting this innovation to advance patient outcomes at The View Hospital,' said Dr Fatih Mehmet Gul, CEO of The View Hospital. The successful procedure highlights The View Hospital's ongoing mission to bring world-class surgical innovation to Qatar. By being the first private healthcare provider in the country to adopt this technology, the hospital continues to set new benchmarks in bariatric and metabolic care, expanding its leadership in minimally invasive and patient-centred solutions.
Qatar Tribune
3 days ago
- Qatar Tribune
WCM-Q shines light on Qatar's path to ‘global excellence' in cancer care, research
Tribune News Network Doha Researchers at Weill Cornell Medicine-Qatar (WCM-Q) have conducted a comprehensive study of Qatar's pioneering national cancer care and research strategy, highlighting the country's significant achievements in improving prevention, detection and treatment of the disease. The report, published in the leading UK medical journal Lancet Oncology, notes the remarkable success of Qatar's investments in advanced clinical and research infrastructure, cutting-edge technologies, and recruitment of highly skilled healthcare professionals over the past two decades, which have transformed the country into a regional leader in cancer care. Areas of particular strength in Qatar's system of cancer care - which has been shaped by the National Cancer Strategy (2010) and the Qatar Cancer Plan (2023-26) - include special expertise in precision and personalized medicine, early detection (based on well-developed screening facilities and schedules), and robustly evidence-based cancer management following diagnosis, leading to improved survival rates. The research, titled 'Qatar national cancer care and research: pioneering strategies for global health excellence,' also highlights areas where some challenges still exist, including late-stage diagnosis, low health literacy relating to cancer among some demographic groups in Qatar, and data collection and long-term analysis. WCM-Q's Dr. Lotfi Chouchane, professor of genetic medicine and professor of microbiology and immunology, is the senior author of the paper. The report, and a subsequent paper also published in Lancet Oncology, additionally highlights the potential for establishing beneficial regional and global collaborations on cancer care and research, particularly with Saudi Arabia and Jordan. This subsequent paper, titled 'Bridging borders for resilience in cancer control in the Middle East: a strategic alliance of Saudia Arabia, Qatar, and Jordan' also provides an epidemiological breakdown of patterns of cancer burden in the three countries. Dr. Murugan Subramanian, senior research associate, is a co-first author of the paper, with Dr. Chouchane serving as a co-senior author. Other researchers who contributed include Sheikh Dr. Mohammed Bin Hamad Al-Thani, director of the Public Health Department at the Ministry of Public Health and associate professor of Clinical Healthcare Policy and Research at WCM-Q and Qatar University; Dr Salha Bujassoum, senior consultant at the National Centre for Cancer Care and Research; Dr. Khalid Rashid Al-Rumaihi, head of the Department of Urology at Hamad Medical Corporation; and Dr. Hilal Lashuel, research development and innovation advisor to the chairperson of Qatar Foundation and executive director of RDI at the Chairperson's Office. Dr. Chouchane said: 'This research shows very clearly that the past two decades have been a huge success story for Qatar in its efforts to establish a truly world-class cancer care and innovation infrastructure. Looking ahead, we identified some challenges to overcome in the areas of community health literacy; cultural sensitivities surrounding important cancer-prevention measures; language barriers; data collection, digitization and long-term analysis; issues around healthcare equity; and the growing global challenge of unhealthy lifestyle choices, which can increase cancer risk. 'We can see, however, that Qatar is already taking steps to address many of these challenges, as is shown by the Qatar Cancer Plan 2023-26, developed by the Ministry of Public Health and the National Cancer Governance Board.' The research also draws attention to Qatar's efforts to prioritize the integration of cutting-edge precision and personalized medicine protocols into clinical practice - a measure which is already having a significant positive impact on survival rates. He added: 'Precision medicine is one of the most promising areas for cancer research and enhanced patient outcomes, but a limiting factor is that it is dependent on good-quality genomic data matched with good-quality clinical data. Therefore, sharing genomic and clinical data with healthcare systems in neighbouring countries who have populations with similar ethnic backgrounds could provide a dramatic boost for precision oncology in the region.'
Qatar Tribune
4 days ago
- Qatar Tribune
Experts convene in Qatar to enhance lymphoma patient care
Tribune News Network Doha Roche Pharmaceuticals, through its local representative Ebn Sina Medical, a fully owned subsidiary of Aamal Company Q.P.S.C., convened a significant workshop dedicated to the advancements in lymphoma treatment, specifically targeting Diffuse Large B-Cell Lymphoma (DLBCL). This high-profile event, known as the Redefining Lymphoma Gulf Countries Annual Forum, served as a platform for knowledge exchange and collaborative discussion among leading hematology experts. Thirteen distinguished professionals, representing Qatar, Kuwait, Oman, Egypt, and the United Kingdom, participated in this intensive forum. The agenda centered on the most current updates in the clinical management pathways for DLBCL, a challenging hematological malignancy. Beyond the presentation of cutting-edge research and therapeutic strategies, the workshop facilitated an invaluable opportunity for these experts to share their firsthand experiences in treating DLBCL patients. They delved into real-world treatment outcomes observed in their respective national healthcare systems, providing a rich tapestry of practical insights that complemented the theoretical advancements Honar Cherif, head of NCCCR in Qatar, remarked, 'Organising such events is crucial for fostering collaboration and continuous medical education. Pharmaceutical companies' role in facilitating these workshops is invaluable as it brings together experts who can exchange knowledge and advance patient care in hematology.'Dr. Wendy Osborne, Consultant Haematologist specialising in Lymphoma at Freeman Hospital, Newcastle, emphasised, 'Sharing experiences and getting exposed to different practices across the world are fundamental to improving patient outcomes. I am highly appreciative of the quality of care in the region, and forums like these are essential for pushing the boundaries of lymphoma treatment and care.' Omar Hamdy, Roche Qatar and Oman Lead, stated, 'Roche is proud to organize The Redefining Lymphoma Gulf Forum, an event that drives hematology innovation. This forum enables Gulf healthcare professionals to share their experiences to improve patient care and create long-term lymphoma treatment strategies, aligning with Roche's core purpose.' As part of Aamal Company's continued commitment to supporting Qatar's healthcare sector, Ebn Sina Medical remains focused on enhancing patient access to innovative treatments through strategic partnerships with leading global pharmaceutical companies.
